Pharma company Roche has been awarded World Health Organization (WHO) prequalification for its cobas HPV test. This move increases access to critical cervical cancer screening tools in low and lower-middle income countries, where the disease is most prevalent and deadly. Each year, over 600,000 women around the world are diagnosed with cervical cancer, with more than 340,000 succumbing to the preventable disease,…
![](https://femtechinsider.com/wp-content/uploads/2023/06/roche-hpv-cobas-test-who-prequalification-1000x658.jpg)